Personalized Targeted Immunomodulation in COVID-19 ARDS

Clinical trial NCT06311448 · COMPLETED

Trial details

NCT number: NCT06311448
Sponsor: Erasmus Medical Center
Status: COMPLETED
Study type: OBSERVATIONAL

COVID-19 Acute Respiratory Distress Syndrome

Start date: 2020-03-02
Primary completion: 2022-02-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.